1-(2-Methoxyphenyl)piperazine → 2-ethyl-3-(2-(4-(2-methoxyphenyl)piperazine-1-yl)ethyl)quinazoline-4(3H)-one
Reaktionsgleichung
[CH2:1]([C:3]1[N:12]([CH2:13][CH2:14][N:15]2[CH2:20][CH2:19][N:18]([C:21]3[CH:26]=[CH:25][CH:24]=[C:23](C(F)(F)F)[CH:22]=3)[CH2:17][CH2:16]2)[C:11](=[O:31])[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[N:4]=1)[CH3:2].[CH3:32][O:33]C1C=CC=CC=1N1CCNCC1>>[CH2:1]([C:3]1[N:12]([CH2:13][CH2:14][N:15]2[CH2:20][CH2:19][N:18]([C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[O:33][CH3:32])[CH2:17][CH2:16]2)[C:11](=[O:31])[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[N:4]=1)[CH3:2]Komponenten
3
Versuchsvorschrift
This compound was prepared in compliance with the procedure described in 7d, using 1-(2-methoxyphenyl)piperazine instead of 1-(3-(trifluoromethyl)phenyl)piperazine.
Aufarbeitung
- customThis compound was prepared in compliance with the procedure
Quellen und Nachweise
- ORD-Eintrag
- ord-c104b7fd6b77427bb3f85ec1e69970a0
- Quelldatensatz
- uspto-grants-2015_10
- Patentnummer
- US09169218B2
Notizen zur Reaktion
Wird geladen…